Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001140361-23-041175
Filing Date
2023-08-24
Accepted
2023-08-24 17:23:46
Documents
2
Group Members
XYLOPHONE ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc20057945_sc13d.htm SC 13D 122551
2 EXHIBIT 99.3 brhc20057945_ex99-3.htm EX-99.3 6507
  Complete submission text file 0001140361-23-041175.txt   130833
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88971 | Film No.: 231203056
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filed by) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations